Murphy Usa Inc SEC Filings

Insider grant and deferral of director compensation — Murphy USA director Jack T. Taylor was granted 83.333 Restricted Stock Units (RSUs) on 09/30/2025 under the 2023 Omnibus Incentive Plan. The RSUs are fully vested and were issued in lieu of the director's quarterly cash retainer; Mr. Taylor elected to defer settlement of these RSUs and associated dividend equivalent units until his termination of board service. The reported grant has a $0 per-unit price and, after the transaction, the filing reports 904.474 shares beneficially owned by the reporting person. The Form 4 was signed on 10/01/2025 by an attorney-in-fact.

Deming Claiborne P, a director of Murphy USA Inc. (MUSA), received 80.128 restricted stock units (RSUs) on 09/30/2025 under the company’s 2023 Omnibus Incentive Plan in lieu of his quarterly cash retainer. The RSUs are fully vested when granted and the reporting person has elected to defer settlement of the RSUs and accrued dividend equivalent units until termination of Board service.

Following the reported grant, the filing shows the reporting person beneficially owns 868.612 shares (directly). The RSUs carry no conversion/exercise price and are reported at a price of $0. The Form 4 was signed on behalf of the reporting person by Gregory L. Smith, attorney-in-fact on 10/01/2025.

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander filed a Schedule 13G reporting shared beneficial ownership of 926,541 shares of Murphy USA Inc. common stock, representing 4.8% of the class (CUSIP 626755102). The filing notes an event on August 25, 2025 that previously brought holdings above 5%, and states that by the date of this filing the reporting persons had ceased to own more than 5%.

The shares are held by entities subject to voting control and investment discretion of Millennium Management LLC and related managers, with no sole voting or dispositive power reported and shared voting and dispositive power of 926,541 shares. The filing includes a Joint Filing Agreement dated August 28, 2025, and signatures from Gil Raviv and Israel A. Englander.

Clyde R. Andrew, President & CEO and director of Murphy USA Inc. (MUSA), reported transactions dated 08/21/2025. He effected a net exercise of stock options that resulted in the acquisition of 22,300 common shares, with 12,090 shares withheld by the company to cover the option exercise price and applicable taxes using the 08/20/2025 closing price of $394.23. After these transactions he beneficially owned 155,652.432 shares directly. The report also discloses indirect holdings of 1,529.964 shares through a 401(k) plan and 75,422 shares held by a limited partnership. The filing was signed by an attorney-in-fact on 08/22/2025.

West Malynda K, EVP & Chief Operating Officer of Murphy USA Inc. (MUSA), reported transactions dated 08/12/2025 on a Form 4. The filing discloses a net exercise-related transaction involving 4,100 shares, with shares withheld by the company to cover the exercise price and taxes using the $378.95 closing price on August 11, 2025. The filing also records dispositions of 2,241 and 1,859 shares at prices shown as $378.95 and $386.2217, respectively.

The report shows 117,388.642 shares beneficially owned following the transactions and 869.814 shares held indirectly in a 401(k) plan (including 14.88 shares acquired via that plan). The filer retains 8,000 stock options with a $76.15 exercise price, granted under the 2013 Long-Term Incentive Plan; vesting schedule is noted in the filing.

Transaction summary: The Form 144 shows an insider of Murphy USA Inc. (MUSA) acquired and immediately sold 1,859 common shares via a stock option exercise. The sale was executed through Fidelity Brokerage Services LLC on the NYSE for an aggregate market value of $717,986.20. The filer reports 19,292,355 shares outstanding for the issuer, so the blocks represent about 0.01% of outstanding stock.

Context and implications: The filing indicates payment in cash and that there were no other sales in the past three months for the reporting person. This appears to be a routine option exercise followed by an immediate sale through an institutional broker, with no additional disclosures or remarks raising material concerns in the form itself.